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Congenital long QT syndrome (LQTS) is characterized by
prolongation of the repolarization phase after cardiac myo-
cyte depolarization. It affects up to 1 in 2000 people and is a
leading cause of sudden cardiac death (SCD) in the young.1
To date, defects in 16 genes that code for transmembrane
cardiac ion channels or accessory proteins have been
implicated in more than 80% of cases. Patients with LQTS
have a long QT interval on surface ECG and are predisposed
to torsades de pointes (TdP). Infants with extremely pro-
longed repolarization may present with bradycardia from
functional 2:1 AV block when the QT interval exceeds the
P-P interval. We present a difﬁcult case of LQTS in a highly
affected child with a rescinded genetic diagnosis and multi-
ple complications from medical therapies.Case report
A biracial full-term female newborn presented on day of life
1 with 2:1 AV block and cardiac arrest due to an extremely
long QT interval (4600 ms) and TdP. Her Caucasian mother
had a normal ECG and a negative family history for SCD.
Her African-American father was unavailable for clinical
evaluation, and his family history was unknown. A single-
chamber epicardial VVI pacemaker was placed through a
limited sternotomy, and propranolol therapy up to 2 mg/kg/
dose tid was initiated. By age 3 months, 2:1 AV block had
resolved, but she developed culture-negative erosion of the
pacemaker generator through the abdominal wall, which
required removal of the chronic system and placement of a
new single-chamber pacemaker system via left thoracotomy
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demonstrated a single sodium channel defect, SCN5A Leu
618 Phe, which supported the diagnosis of LQT3. Subsequent
pacemaker interrogation demonstrated recurrent nonsustained
TdP, so mexiletine was added to the medical regimen.
At 2 years of age, the patient had syncope due to non-
sustained ventricular ﬁbrillation (VF) despite pacing, high-
dose propranolol at 2 mg/kg per dose tid, and mexiletine 4 mg/
kg/dose. Her pacemaker system was upgraded to an epicardial
implantable cardioverter-deﬁbrillator (ICD) with addition of a
subcutaneous coil and active abdominal generator. Nadolol 1
mg/kg/dose qd was added to the medical regimen for addi-
tional beta-blockade effect after a persistent high resting heart
rate, normal blood pressures, and repeat TdP were demon-
strated on propranolol and mexiletine (Figure 2A). The patient
still received multiple subsequent appropriate shocks. Many
ventricular arrhythmias occurred in the setting of low mex-
iletine levels due to parental medical noncompliance. Behav-
ioral and family therapy were provided, and mexiletine drug
levels were monitored. At the age of 3 years, the patient had
repeat syncope because the epicardial ICD system failed to
deﬁbrillate several episodes of TdP and VF at maximum
voltage output. The epicardial system was abandoned, and a
dual-chamber endocardial ICD system was implanted through
the left subclavian vein (Figure 2B). Because of the patient’s
small size (15 kg with a narrow chest diameter), the ICD can
was electively placed in the abdomen. Despite atrial pacing at
80 bpm (to limit bradycardia and stabilize the heart rate) and
weight and/or serum level adjusted doses of propranolol,
nadolol, and mexiletine (see earlier), she continued to receive
repeat appropriate shocks (Figure 3A). The patient was awake
during several appropriate ICD shocks for TdP and subse-
quently developed posttraumatic stress disorder.
A left-sided cervical sympathectomy was performed
when the patient was 4 years old. Commercial genetic testing
at that time using Sanger sequencing for KCNQ1 (LQT1),
KCNH2 (LQT2), SCN5A (LQT3), KCNe1 (LQT5), and
KCNE2 (LQT6) conﬁrmed an SCN5A Leu 618 Phe (exon
12, 1852 C4T, rs45488304) gene mutation classiﬁed as a
class II variant (possible deleterious mutation). The ICD
generator experienced battery depletion, which requiredpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Genetic testing for inherited arrhythmia syndromes and
other disorders is probabilistic in nature, and
interpretation of results may change over time as we
amass detailed long-term clinical and genetic test data.
 The rate of complications for implanted cardiac
devices in children is higher than in adults.
Heart Rhythm Case Reports, Vol 1, No 6, November 2015390replacement when the patient was 9 years of age. When the
patient was 11 years old, the right atrial endocardial pace-Figure 1 A: Resting ECG at age 3 months. B: Chest
and abdomen X-ray ﬁlms at the time of abdominal
pacemaker generator erosion. C: Postoperative chest
and abdomen X-ray ﬁlms showing second single-cham-
ber epicardial bipolar pacemaker system. At this time, the
cardiac silhouette appeared enlarged but the echocardio-
gram was normal without effusion or chamber
enlargement.sense lead fractured, and the patient had repeat TdP and VF.
A new endocardial right atrial lead was implanted and
tunneled to the abdominal generator. The endocardial
ventricular pace-sense lead failed after 9 years when the
patient was 12 years old (noise was identiﬁed on ventricular
electrograms before inappropriate therapies occurred). An
open chest ICD extraction, right-sided cervical sympathec-
tomy, tricuspid valve repair (endocardial right ventricular
lead had perforated the anterior leaﬂet), and placement of a
new epicardial ICD system were performed (Figure 3B).
The 12-year-old child went on to have more episodes of
TdP and VF with successful shocks despite lenient
Figure 2 A: Chest and abdomen X-ray ﬁlms at the time of epicardial bipolar pacemaker upgrade to an epicardial implantable cardioverter-deﬁbrillator (ICD)
system, including a subcutaneous coil placed to the left of the sternum and an abdominal ICD generator, at age 2 years. B: Chest and abdomen X-ray ﬁlms at the
time of endocardial ICD system placement, including extraction of subcutaneous ICD coil and addition of endocardial right atrial pacing and right ventricular
single-coil ICD leads with tunneling of leads to the abdominal ICD generator, at age 3 years.
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pranolol, nadolol, and mexiletine doses, and therapeutic
mexiletine levels. Recently, the patient’s sodium channel
SCNA5A Leu 618 Phe gene variation was downgraded from
a possible LQTS-associated mutation to a likely benign class
III variant that is common in patients of African-American
descent, and we are now considering the withdrawal of
mexiletine therapy. Therapy with alternative drugs, includ-
ing spironolactone and ranolazine, will be considered in the
future.Discussion
Most patients with LQTS respond favorably to beta-blocker
therapy, with resolution of TdP and syncope and mitigationof the risk for SCD. A minority of patients with more severe
disease or medical noncompliance requires multiple drug
therapy, ICD, or cervical sympathectomy. It is rare for
patients with LQTS to have frequent TdP and VF in the
setting of optimal medical and surgical management. This
young child with an extremely long QT interval on surface
ECG remains a genetic enigma and continues to suffer
from TdP and VF despite our best efforts at prevention.
She reminds us, with 41 appropriate high-voltage therapies
before age 13 years, that despite the decades of knowledge
we have accumulated about this prototypical inherited
arrhythmia syndrome, we still have a long way to go before
we fully understand all causes and optimal treatments for
difﬁcult cases of congenital LQTS.2 With 7 pacemaker and
ICD surgeries before age 13 years, this case also illustrates
Figure 3 A: Stored ECGs during dual-chamber paced rhythm and episode of ventricular tachycardia that rapidly degenerated to ventricular ﬁbrillation,
triggering a successful implantable cardioverter-deﬁbrillator (ICD) shock. B: Chest and abdomen X-ray ﬁlms at the time of endocardial ICD system extraction
and placement of a new epicardial system, including atrial and ventricular bipolar pace-sense leads, posterior and leftward pericardial coil, and abdominal ICD
generator, at age 11 years.
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lead malfunctions, infections, and other complications
despite modern era improvements in implanted cardiac
device therapies.References
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